Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer

Neuroendocrine-differentiated prostate cancer (NEPC) is a rare pathophysiology. We herein report a patient diagnosed with conventional prostate adenocarcinoma before hormone therapy, which was later diagnosed as NEPC. The nadir of prostate-specific antigen (PSA) was achieved once. However, adenocarc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Hiroshi, Nakajima, Kenichi, Kadomoto, Suguru, Mizokami, Atsushi, Ikeda, Hiroko, Wakabayashi, Hiroshi, Kinuya, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262717/
https://www.ncbi.nlm.nih.gov/pubmed/29877274
http://dx.doi.org/10.2169/internalmedicine.0630-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262717/
https://www.ncbi.nlm.nih.gov/pubmed/29877274
http://dx.doi.org/10.2169/internalmedicine.0630-17

Ejemplares similares